How many stocks are there of Cardlytics?
The current number of stocks of Cardlytics is 36.49 M undefined.
Cardlytics Stocks 2024
Cardlytics Stocks
36.49 M
Ticker
CDLX
ISIN
US14161W1053
WKN
A2JDMC
In 2024, Cardlytics had 36.49 M outstanding stocks, a 0% change from the 36.49 M stocks in the previous year.
The Cardlytics Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2026e | 36.49 |
| 2025e | 36.49 |
| 2024e | 36.49 |
| 2023 | 36.49 |
| 2022 | 33.4 |
| 2021 | 32.2 |
| 2020 | 27.2 |
| 2019 | 23.7 |
| 2018 | 19.1 |
| 2017 | 20 |
| 2016 | 19.5 |
| 2015 | 19.5 |
Cardlytics shares outstanding US14161W1053 · A2JDMC
The number of shares was Cardlytics in 2023 — This indicates how many shares 36.488 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Cardlytics earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Cardlytics's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Cardlytics’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cardlytics's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2015 | 19.5 M Aktien |
| 2016 | 19.5 M Aktien |
| 2017 | 20 M Aktien |
| 2018 | 19.1 M Aktien |
| 2019 | 23.7 M Aktien |
| 2020 | 27.2 M Aktien |
| 2021 | 32.2 M Aktien |
| 2022 | 33.4 M Aktien |
| 2023 | 36.49 M Aktien |
| 2024e | 36.49 M Aktien |
| 2025e | 36.49 M Aktien |
| 2026e | 36.49 M Aktien |
Cardlytics Aktienanalyse
What does Cardlytics do?
Cardlytics Inc is an Atlanta, Georgia-based adtech company that has developed a proprietary online purchase data platform, allowing advertisers to conduct targeted advertising campaigns based on consumer interests and shopping behavior. The company was founded in 2008 by Scott Grimes and Lynne Laube, with the goal of launching the loyalty program "Cardlytics Rewards". The program offered bank customers discounts and rewards for purchases at popular retailers. However, the company quickly shifted its focus to developing its online purchase data platform, which is now the core business of the company. Cardlytics' business model is based on banks (such as Wells Fargo or Bank of America) being able to offer their customers personalized ads based on their shopping behavior. Cardlytics works with these banks to capture and analyze their transaction data without collecting personal identifiable information. The data is then used to provide personalized advertising campaigns across various digital channels (such as mobile apps, email, online advertising). Cardlytics operates in three segments: Bank Partnerships, Direct and Native Advertising, and Analytics and Insights. Bank Partnerships is the largest segment and represents the main revenue source for the company. In this segment, Cardlytics works with over 2,000 banks in the US, as well as in the UK, Australia, and Canada, to provide personalized advertising campaigns for their customers. The Direct and Native Advertising segment of Cardlytics includes partnerships with retailers and brands that advertise on Cardlytics' online purchase data platform. These ads are delivered directly to consumers who have recently shopped at one of the participating retailers. Native advertising includes placements in shopping bags, receipts, and other transaction-related emails. Direct advertising includes ads placed in digital channels such as social media and mobile applications. Cardlytics' Analytics and Insights segment provides insights into consumer shopping behavior. This includes data analytics, reports, and dashboards that give retailers and brands an overview of the effectiveness of their advertising campaigns and help them optimize their advertising strategy. Cardlytics' platform offers several products. One of the main products is purchase data analytics, where the company collects and analyzes transaction data to gain a better understanding of how consumers shop and what products they prefer. Another main product is offering personalized advertising campaigns based on consumer purchase data and interests. Cardlytics also offers a tracking platform that allows advertisers and retailers to track ad performance and return on investment. With this tracking platform, clients can see how their ads are influencing consumers, which consumers are responding to which ads, and how the ad campaign can be optimized to improve results. Overall, Cardlytics has a unique position in the adtech industry, as it can offer personalized advertising based on transaction data. The company has built partnerships with a variety of banks and retailers and offers a wide range of products and services to meet the needs of its clients. Cardlytics ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Cardlytics's Shares Outstanding
Cardlytics's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Cardlytics’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Cardlytics’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Cardlytics’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Cardlytics stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Cardlytics are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Cardlytics evolved in recent years?
The number of shares of Cardlytics has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Cardlytics as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Cardlytics?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Cardlytics pay?
Over the past 12 months, Cardlytics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cardlytics is expected to pay a dividend of 0 USD.
What is the dividend yield of Cardlytics?
The current dividend yield of Cardlytics is .
When does Cardlytics pay dividends?
Cardlytics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Cardlytics?
Cardlytics paid dividends every year for the past 0 years.
What is the dividend of Cardlytics?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Cardlytics located?
Cardlytics is assigned to the 'Communication' sector.
Wann musste ich die Aktien von Cardlytics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cardlytics from 8/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/7/2024.
When did Cardlytics pay the last dividend?
The last dividend was paid out on 8/7/2024.
What was the dividend of Cardlytics in the year 2023?
In the year 2023, Cardlytics distributed 0 USD as dividends.
In which currency does Cardlytics pay out the dividend?
The dividends of Cardlytics are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Cardlytics stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Cardlytics
Our stock analysis for Cardlytics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cardlytics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
